Search hospitals

>

Georgia

>

Atlanta

Emory University Hospital Midtown

Claim this profile

Atlanta, Georgia 30308

Global Leader in Lung Cancer

Global Leader in Breast Cancer

Conducts research for Cancer

Conducts research for Breast cancer

Conducts research for Non-Small Cell Lung Cancer

366 reported clinical trials

69 medical researchers

Photo of Emory University Hospital Midtown in AtlantaPhoto of Emory University Hospital Midtown in AtlantaPhoto of Emory University Hospital Midtown in Atlanta

Summary

Emory University Hospital Midtown is a medical facility located in Atlanta, Georgia. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Breast cancer, Non-Small Cell Lung Cancer and other specialties. Emory University Hospital Midtown is involved with conducting 366 clinical trials across 571 conditions. There are 69 research doctors associated with this hospital, such as Conor Steuer, Ticiana A. Leal, Olatunji Alese, and Mehmet Bilen, MD.

Area of expertise

1

Lung Cancer

Global Leader

Emory University Hospital Midtown has run 64 trials for Lung Cancer. Some of their research focus areas include:

Stage IV
Stage III
Stage II
2

Breast Cancer

Global Leader

Emory University Hospital Midtown has run 62 trials for Breast Cancer. Some of their research focus areas include:

Stage IV
HER2 negative
ER positive

Top PIs

Clinical Trials running at Emory University Hospital Midtown

Lung Cancer

Breast Cancer

Skin Cancer

Prostate Cancer

Cancer

Breast cancer

Liver Cancer

Ovarian Cancer

Pancreatic Cancer

Laryngeal Cancer

Image of trial facility.

Lurbinectedin + Radiotherapy

for Small Cell Lung Cancer

This phase I trial aims to determine if it is safe to use palliative radiotherapy and lurbinectedin at the same time to treat small cell lung cancer that has spread outside of the chest and that has grown after being treated with chemotherapy (extensive stage). Lurbinectedin kills tumor cells by blocks a process called transcription that small cell lung cancer relies on to survive. It also damages the deoxyribonucleic acid (DNA) of tumor cells, which is similar to the way radiation kills tumor cells. Palliative radiotherapy is a routine medical treatment for patients who have lung cancer that has spread to other parts of the body (metastatic), and is used to relieve symptoms caused by cancer or to patients from developing symptoms. This trial may help doctors understand if treating patients with lurbinectedin and palliative radiotherapy at the same time would make them both work better than either one alone or if they could cause more side effects for patients when given together.

Recruiting

2 awards

Phase 1

16 criteria

Image of trial facility.

Ceralasertib + Durvalumab

for Non-Small Cell Lung Cancer

This phase III trial compares the effect of adding AZD6738 to durvalumab versus durvalumab alone to increase time without cancer in patients with non-small cell lung cancer, following treatment with chemotherapy and surgery. AZD6738 may stop the growth of tumor cells and may kill them by blocking some of the enzymes needed for cell growth. Durvalumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Adding AZD6738 to durvalumab may increase time without cancer in patients with non-small cell lung cancer, following treatment with chemotherapy and surgery.

Recruiting

2 awards

Phase 3

10 criteria

Image of trial facility.

Radiation Therapy

for Brain Metastasis

This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.

Recruiting

2 awards

Phase 3

12 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Emory University Hospital Midtown?

Where is Emory University Hospital Midtown located?

Who should I call to ask about financial aid or insurance network?

What insurance does Emory University Hospital Midtown accept?

What awards or recognition has Emory University Hospital Midtown received?